- Home
- LVLU vs TPST Comparison
LVLU vs TPST Comparison
Compare LVLU & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- TPST
- Stock Information
- Founded
- LVLU 1996
- TPST 2011
- Country
- LVLU United States
- TPST United States
- Employees
- LVLU N/A
- TPST N/A
- Industry
- LVLU Catalog/Specialty Distribution
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- LVLU Consumer Discretionary
- TPST Health Care
- Exchange
- LVLU Nasdaq
- TPST Nasdaq
- Market Cap
- LVLU 28.6M
- TPST 40.4M
- IPO Year
- LVLU 2021
- TPST N/A
- Fundamental
- Price
- LVLU $0.46
- TPST $0.86
- Analyst Decision
- LVLU Hold
- TPST Strong Buy
- Analyst Count
- LVLU 3
- TPST 3
- Target Price
- LVLU $1.58
- TPST $21.67
- AVG Volume (30 Days)
- LVLU 17.9K
- TPST 636.7K
- Earning Date
- LVLU 03-27-2025
- TPST 03-18-2025
- Dividend Yield
- LVLU N/A
- TPST N/A
- EPS Growth
- LVLU N/A
- TPST N/A
- EPS
- LVLU N/A
- TPST N/A
- Revenue
- LVLU $324,699,000.00
- TPST N/A
- Revenue This Year
- LVLU N/A
- TPST N/A
- Revenue Next Year
- LVLU $1.72
- TPST N/A
- P/E Ratio
- LVLU N/A
- TPST N/A
- Revenue Growth
- LVLU N/A
- TPST N/A
- 52 Week Low
- LVLU $0.46
- TPST $0.70
- 52 Week High
- LVLU $1.99
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- LVLU 11.81
- TPST 46.96
- Support Level
- LVLU $0.48
- TPST $0.77
- Resistance Level
- LVLU $0.77
- TPST $0.85
- Average True Range (ATR)
- LVLU 0.06
- TPST 0.05
- MACD
- LVLU -0.02
- TPST 0.00
- Stochastic Oscillator
- LVLU 3.46
- TPST 59.46
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.